SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001072613-14-000100
Filing Date
2014-02-14
Accepted
2014-02-13 17:51:12
Documents
1
Group Members
ALEX ZISSONERIC AGUIARJAMES E. THOMASPETE MCNERNEYTHOMAS MCNERNEY & PARTNERS II LLCTMP ASSOCIATES II L.P.TMP NOMINEE II LLC

Document Format Files

Seq Description Document Type Size
1 CELATOR PHARMACEUTICALS, INC. tmp-sch13g_17620.htm SC 13G 243656
  Complete submission text file 0001072613-14-000100.txt   245345
Mailing Address 303B COLLEGE ROAD EAST PRINCETON NJ 08540
Business Address 303B COLLEGE ROAD EAST PRINCETON NJ 08540 (609) 243-0123
Celator Pharmaceuticals Inc (Subject) CIK: 0001327467 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-87438 | Film No.: 14608273
SIC: 2834 Pharmaceutical Preparations

Mailing Address 60 South Sixth Street Suite 3620 Minneapolis MN 55402
Business Address 60 South Sixth Street Suite 3620 Minneapolis MN 55402 612-456-8660
Thomas, McNerney & Partners II L.P. (Filed by) CIK: 0001369574 (see all company filings)

IRS No.: 721618589
Type: SC 13G